ASTRO Issues First Guideline on Radiation Therapy for Cervical Cancer
There is strong evidence supporting the use of radiation therapy for nonmetastatic cervical cancer.
Cervical Cancer
Pap/HPV Cotesting Better for Cervical Cancer Screening in Over 30s
Dr Harvey W. Kaufman and colleagues examined the results of LBC/HPV cotesting in 13,633,071 women aged ≥30 years, tested in 2010 to 2018.
Artificial Intelligence Provides Benefit for Cervical Cancer Screening
For women undergoing HPV-based cervical cancer screening, automated evaluation of p16/Ki-67 dual-stained slides reduces the number of colposcopies compared with current standards.
Copper Intrauterine Devices Tied to Lower Risk for Cervical Cancer
Findings based on comparison to hormonal intrauterine devices.
Cervical Cancer Screening Remains Low in Women Ages 45 to 65 Years
Screening rates are insufficient to reduce cervical cancer incidence.
Stress Linked to Mortality in Cervical Cancer
Researchers sought to identify the potential influence of stress-related psychiatric disorders and stressful life events on cancer-specific mortality in women with cervical cancer.
Higher Surgical Volume May Improve Outcomes in Cervical Cancer
Findings show radical hysterectomy at high-volume centers tied to better survival in early cervical cancer.
Some Cervical Cancer Screening Strategies More Cost-Effective
Most lifetime QALYs seen with cytologic testing every 3 years, repeated for ASC-US.
CDC: Recent Decline Seen in High-Grade Cervical Lesions
Vast majority of cervical precancer cases attributable to HPV types targeted by 9-valent HPV vaccine
Decline Observed in HPV Type 16/18 Cervical Precancers in US
The proportion of human papillomavirus (HPV) 16/18-positive cervical intraepithelial neoplasia grades 2 to 3 or adenocarcinoma in situ (CIN2+) declined from 2008 to 2014.
-
Loading...
-
Loading...
Next post in Oncology Information Center
